Japan’s Toshiba Corp faces a Friday, March 31, deadline to win Chinese antitrust approval to sell its prized US$18 billion memory-chip business by end-March, raising the possibility the deadline may be missed and that it will seek alternatives such as an IPO.
The conglomerate agreed last year to sell the world’s second-biggest producer of NAND flash memory chips to a consortium led by US private equity firm Bain Capital to plug a huge financial hole left by the bankruptcy of its US nuclear unit.
Toshiba no longer faces immediate insolvency or a delisting even if it does not meet the end-March deadline for the sale as it has raised funds from a share issue late last year, but the deal is still key to its plan to rebound from a US$1.3 billion accounting scandal and a crisis in the nuclear power business.
Missing the end-March deadline for the sale of the chip unit to the Bain consortium gives Toshiba the option of walking away without penalties, people briefed on the matter said.
Those people said Toshiba could listen to activist shareholders who oppose the sale saying the US$18 billion price tag undervalues the business.
Full Content: The Japan Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI